| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 09/22/2009 | US7592373 Metabolism diosrders; eating disorders; obesity; antidiabetic agents; incontinence; melanin concentrating hormone; 3-[4-(4-methylpiperidin-1-ylmethyl)phenyl]propynoic acid-(4'-chloro-2'-fluorobiphenyl-4-yl)amide, for example |
| 09/22/2009 | CA2487450C (2s)-2-ethylphenylpropanoic acid derivatives |
| 09/17/2009 | WO2009112203A1 Process for preparing a diphenylazetidinone |
| 09/17/2009 | WO2009111830A1 Conjugated unsaturated compounds |
| 09/17/2009 | WO2009093916A3 Derivatives of aminoalkanols, method of obtaining aminoalkanols and their use |
| 09/17/2009 | US20090233966 Analogues of the Azinomycins as Anti-Tumour Agents and as Prodrugs |
| 09/16/2009 | EP2099745A2 Preparation of 3,4-dihydroisoquinolines from an acid and an amine |
| 09/16/2009 | CN100540547C Inhibitors of histone deacetylase |
| 09/15/2009 | US7589232 5-[(3-Cyclopentylpropanoyl)(4-dec-1-ynylbenzyl)amino]-2-hydroxybenzoic acid; inflammatory disorder, obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglycerimia |
| 09/15/2009 | US7589220 Inhibitors of the anandamide transporter |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | US7589072 carrier having guanidinium groups enhancing drug delivering across a biological membrane, nuclear membrane or blood-brain barrier into a cell; an ionic complex through ionic bonds between the carrier and the drug or diagnostic reagent |
| 09/11/2009 | WO2009110942A2 Generation of combinatorial synthetic libraries and screening for novel proadhesins and nonadhesins |
| 09/11/2009 | WO2009110002A1 Novel efflux pump inhibitors |
| 09/11/2009 | WO2009109996A2 Novel cationic amphiphiles with quinic acid head-groups for dna vaccination |
| 09/10/2009 | US20090227811 Method for Producing Acetoacetic Acid Arylamides |
| 09/10/2009 | US20090227672 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 09/10/2009 | US20090227604 Vitamin d receptor modulators |
| 09/10/2009 | US20090227453 Forumlations |
| 09/09/2009 | EP2098502A1 Compounds suitable for use in inks and inks having such compounds |
| 09/09/2009 | EP2014643A4 Para-ethoxyaniline derivatives increasing the antiknock rating of hydrocarbon fuels and compositions based thereon |
| 09/09/2009 | CN101528671A MTP inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives |
| 09/08/2009 | US7586008 For inducing general anesthesia, sedation, and/or hypnotic or sleep effects in patient |
| 09/08/2009 | US7585997 Compounds and compositions for treating dysproliferative diseases, and methods of use thereof |
| 09/08/2009 | US7585929 A cell growth substrate made from a polyester containing tyrosine derived biphenol monomer and a dicarboxylic acid monomer |
| 09/08/2009 | CA2478066C Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 09/08/2009 | CA2334010C Novel peroxidase substrates and their use in catalyzed reporter deposition |
| 09/03/2009 | WO2009106713A2 New class of cationic lipids for transporting active agents into cells |
| 09/03/2009 | WO2009076234A3 Synthesis methods of histone deacetylase inhibitors (hdacis) |
| 09/03/2009 | US20090221852 Preparation of an Atorvastatin Intermediate |
| 09/03/2009 | CA2708988A1 New class of cationic lipids for transporting active agents into cells |
| 09/02/2009 | EP2094263A1 2-adamantyl-butyramide derivatives as selective 11 beta-hsd1 inhibitors |
| 09/02/2009 | CN101519368A Small molecule entry inhibitors |
| 09/02/2009 | CN101519363A Substituted naphthylalanine derivative used as protein tyrosine phosphatase 1B (PTP1B) inhibitor |
| 09/01/2009 | US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 09/01/2009 | US7582306 N-(hydroxy-sulfato or phosphato-alkanoyl) fatty amines; excellent permeability barrier, improved water solubility; skin has improved moisture retention |
| 08/27/2009 | WO2009071957A3 Novel peptides and amino acid derivatives, pharmaceutical compositions containing same and the use of these compounds |
| 08/27/2009 | WO2006087393A3 Structural analogues of avenanthramides, their use in compositions useful in the treatment of dermatological disorders |
| 08/26/2009 | EP2091955A1 Alkoxy compounds for disease treatment |
| 08/26/2009 | EP2091914A1 Transdermal delivery systems of peptides and related compounds |
| 08/26/2009 | EP1819693B1 Antithrombotic diamides |
| 08/26/2009 | EP1414780B1 Interfacial method of preparing ester-substituted diaryl carbonates |
| 08/26/2009 | CN101516833A Tartrate derivatives for use as coagulation factor IXa inhibitors |
| 08/26/2009 | CN101516823A Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 08/26/2009 | CN101514193A Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[1(r)-(5-methyl-2-furanyl) propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide |
| 08/26/2009 | CN101514168A Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[1(r)-(5-methyl-2-furanyl) propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide |
| 08/25/2009 | US7579376 N-geranoyltyrosine and N-geranoylcycteine as excellant antitumor and anticarcinogenic agents |
| 08/20/2009 | WO2009100890A1 Products made of o-acylated hydroxycarboxylic acids and amino acids, the production, biological activities, cosmetically or pharmaceutically effective compositions and use thereof, particularly as food additives, and as cosmetic additives |
| 08/20/2009 | US20090209635 Topical cromolyn formulations |
| 08/19/2009 | EP2089355A2 Modulators of glucocorticoid receptor, ap-1, and/or nf- kappa b activity and use thereof |
| 08/19/2009 | CN101511808A Diaryl ether derivatives and uses thereof |
| 08/19/2009 | CN101511780A Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as CPT-inhibitors |
| 08/19/2009 | CN100529068C Microorganisms and processes for enhanced production of pantothenate |
| 08/19/2009 | CN100528872C Tetrahydro-proto-berberine compounds, their preparing method, composition and use |
| 08/18/2009 | US7576129 Carboxylic acid compounds |
| 08/18/2009 | CA2124059C Octacyclodepsipeptides having an endoparasiticidal action |
| 08/13/2009 | WO2009099902A1 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors |
| 08/13/2009 | WO2008080268A8 Derivates of substituted tartaric aicd and usage for preparating beta secretase inhibitors |
| 08/13/2009 | US20090203906 4-[((4-carboxybutyl){2-[2-({4-[2-(4-hydroxyphenyl)ethyl]benzyl}oxy)phenyl]-ethyl}amino)methyl]benzoic acid, which stimulate soluble guanylate cyclase via a novel mechanism of action, used for the treatment of cardiovascular disorders and fibrotic disorders |
| 08/13/2009 | CA2713139A1 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors |
| 08/12/2009 | EP2086322A1 Non-steroidal brassinosteroid mimetic |
| 08/12/2009 | EP1379257B1 Prodrugs of anticancer agents employing substituted aromatic acids |
| 08/12/2009 | EP1089988B1 Fluorophenyl resin compounds |
| 08/12/2009 | CN101506149A Prolyl hydroxylase inhibitors and methods of use |
| 08/12/2009 | CN101506148A Inhibitors for GLYT-1 |
| 08/12/2009 | CN101506147A A process for the manufacture of snac (n-(8-[2-hydroxybenzoyl]-amino) salcaprozate sodium) |
| 08/12/2009 | CN101503373A 2-amino-1-(4-nitro phenyl)-1-ethanol metalloid protease inhibitor, and preparation and use thereof |
| 08/12/2009 | CN101502524A Application of acetyl-fluorobenzene salicylamide compound in preparing anti-tumor medicament |
| 08/12/2009 | CN100526265C Method for selective reduction of aromatic compounds |
| 08/11/2009 | US7572790 Biphenyl carboxylic amide p38 kinase inhibitors |
| 08/11/2009 | CA2368688C Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 08/11/2009 | CA2342062C Rheological additives and paint and coating compositions containing such additives exhibiting improved intercoat adhesion |
| 08/06/2009 | WO2009096571A1 Novel compound, method of synthesis thereof, and oil additive |
| 08/06/2009 | WO2009096526A1 Carboxylic acid compound or salt thereof |
| 08/06/2009 | WO2009062082A3 Selective estrogen receptor modulator compositions and methods for treatment of disease |
| 08/06/2009 | US20090197965 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 08/05/2009 | EP1383731B1 Biaryl compounds as serine protease inhibitors |
| 08/05/2009 | CN101500997A PARP inhibitors |
| 08/05/2009 | CN100522944C Carboxylic acid derivative and thereof |
| 08/05/2009 | CN100522907C Method for producing aromatic compound dimer |
| 08/05/2009 | CN100522151C Compounds for treatment of inflammation, diabetes and related disorders |
| 08/04/2009 | US7569727 Pesticidally active ketone and oxime derivatives |
| 08/04/2009 | US7569724 Antiproliferative agnets; anticancer agents; skin disorders |
| 08/04/2009 | US7569601 Such as (2E)-3-{4-[1-ethyl-2,2-bis(4-hydroxyphenyl)ethenyl]phenyl}-2-propenoic acid; for selective estrogen receptor modulation; menopausal or postmenopausal disorders, vasomotor symptoms, urogenital or vulvar vaginal atrophy, atrophic vaginitis, female sexual dysfunction, breast cancer, osteoporosis |
| 07/30/2009 | WO2009092795A1 Use of ester amides as solvents, ester amides as such, and method for preparing ester amides |
| 07/30/2009 | US20090192192 Inhibitors of biofilm formation of gram-positive and gram-negative bacteria |
| 07/30/2009 | CA2712222A1 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use |
| 07/29/2009 | EP2083005A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 07/28/2009 | US7566803 Vitamin D receptor modulators |
| 07/23/2009 | WO2009091506A2 Polyvinyl ultraviolet light absorbers for personal care |
| 07/23/2009 | WO2008076427A3 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| 07/23/2009 | US20090186941 Organic sulfur compounds and use thereof |
| 07/23/2009 | US20090186790 Photo-labile pro-fragrance conjugates |
| 07/22/2009 | EP2080752A1 Pesticidally active ketone and oxime derivatives |
| 07/22/2009 | EP2079678A2 Selective tr-beta 1 agonist |
| 07/22/2009 | CN101486675A 2- and 2,5-substituted phenylketoenols |
| 07/22/2009 | CN101486666A Alpha, beta-phenyl substituted acrylic amide derivative with blood fat regulating function |
| 07/22/2009 | CN101486665A Preparation of agomelatine intermediate 2-(7-methoxy-1-naphthyl) acetamide |
| 07/22/2009 | CN100516028C Method for preparing high-purity p-chloro-m-nitroacetoacetanilide |
| 07/21/2009 | US7563888 Process for the preparation of diphenyl azetidinone derivatives |